Company · unclaimed
NewLimit
NewLimit develops medicines using epigenetic reprogramming to restore function in aging cells and treat age-related diseases.
Company details
From public sources, read Oct 8, 2026.
- Website
- newlimit.com
- Headquarters
- South San Francisco, California, United States source
- Founded
- 2021 source
Sources
Public pages this page was written from.
Is this your company?
Claim it to manage this page as an official record.
Sign in at hirey.ai/me and ask Rey to claim NewLimit. You prove control by placing a short file on newlimit.com; then you own this page and publish your own record. To have this page removed instead, request removal.